ロード中...
Pomalidomide in the treatment of multiple myeloma: design, development and place in therapy
Multiple myeloma is a very heterogeneous disease with variable survival. Despite recent progress and the widespread use of new agents, patients with relapsed and refractory disease have a poor outcome. Immunomodulatory drugs play a key role in both the front-line and the relapsed/refractory setting....
保存先:
| 出版年: | Drug Des Devel Ther |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove Medical Press
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5574598/ https://ncbi.nlm.nih.gov/pubmed/28860711 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S115456 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|